In this issue:
10 vs 5 years of adjuvant tamoxifen in ER+ BC
Overdiagnosis in screening mammography in Denmark
6 vs 12 months of adjuvant trastuzumab
Zoledronic acid, ONJ and QoL
Persistence with endocrine therapy
Cosmetic breast implants hinder BC detection
Withhold radiation in older early-stage BC?
Exemestane vs anastrozole in early BC
Moderate alcohol consumption appears safe after BC treatment
Please login below to download this issue (PDF)